News Focus
News Focus
Replies to #82088 on Biotech Values
icon url

dewophile

08/10/09 9:31 AM

#82089 RE: genisi #82088

thanks genisi

"This SGP's presentation is news:

"High Sustained Virologic Response (SVR) in Genotype 1 (G1) Null Responders to Peg-Interfeon alfa-2b (P) plus Ribavirin (R) When Treated with Boceprevir (Boc) Combination Therapy.""

it sure is! It will be interesting to compare SVR to telaprevir - particularly since this is a much more homogeneous population to compare across studies